EUVIMEDEUVIMED entdecken
Crossref

Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication

Helena Rodriguez-Gonzalez, Aida Ormazabal, Mercedes Casado, Angela Y Arias, Clara Oliva, Maria Barranco-Altirriba, Ricard Casadevall, Francesc García-Cuyas, Andrés Nascimento, Carlos Ortez, Daniel Natera-de Benito, Thais Armangué und 8 weitere

Clinical Chemistry · 2024

DOI: 10.1093/clinchem/hvae139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Helena Rodriguez-Gonzalez und 19 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biochemistry Department, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Hydroxyindoleacetic Acid, Homovanillic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebrospinal fluid (CSF) homovanillic (HVA), and 5-hydroxyindoleacetic acids (5-HIAA) are biomarkers of neurological diseases affecting the dopaminergic and serotoninergic pathways. Establishing reference intervals for these metabolites faces the challenges of a lack of healthy controls and a negative correlation with age, making stratified intervals unrealistic. We propose a pipeline to determine continuous reference intervals for HVA and 5-HIAA using an indirect method. We also studied the confounding effects of different variables and explored the impact of antiepileptic and neuroleptic treatments on HVA and 5-HIAA values.

Methods

The study used least squares regression to fit age–concentration curves from a cohort of pediatric patients (n = 1533), where the residuals represent metabolite values excluding age effect. Presuming that HVA and 5-HIAA primary deficiencies characterize a distinct subpopulation, we fitted a two-component finite mixture model in age-normalized data and set reference intervals at the central 95% of the nondeficient population.

Results

Patients with primary genetic deficiencies of HVA and/or 5-HIAA consistently fall outside the proposed continuous reference intervals. Using the new continuous reference intervals reduces the number of secondary deficiencies detected compared with using stratified values. No correlations were observed between CSF HVA and 5-HIAA values across the studied drug categories (antiseizure and neuroleptic medications). In addition, biopterin values positively influenced both metabolite concentrations.

Conclusion

The proposed continuous reference intervals caused a substantial reduction in the number of secondary deficiencies detected, most of which demonstrated no conclusive correlations between the diseases and altered HVA and 5-HIAA values.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxyindoleacetic AcidHomovanillic AcidHumansChildChild, PreschoolMaleInfantFemaleAdolescentReference ValuesAnticonvulsantsBiomarkersAntipsychotic AgentsInfant, NewbornCohort Studies

Substanzen

Hydroxyindoleacetic AcidHomovanillic AcidAnticonvulsantsBiomarkersAntipsychotic Agents

Autor:innen und Institutionen

  • Clinical Biochemistry Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • B2SLab, Departament d'Enginyeria de Sistemes, Automàtica i Informàtica Industrial, Universitat Politècnica de Catalunya, Barcelona, Spain.
  • Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
  • Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
  • Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain.
  • Departament de Bioquímica Clinica, Institut de Bioquímica Clínica, Centre de Diagnostic Biomedic, Hospital Clinic, Barcelona, Spain.

ORCID-Profile: Rafael Artuch

Zitieren

APA

Rodriguez-Gonzalez, H., Ormazabal, A., Casado, M., Arias, A. Y., Oliva, C., Barranco-Altirriba, M., Casadevall, R., García-Cuyas, F., Nascimento, A., Ortez, C., Natera-de Benito, D., Armangué, T., O'Callaghan, M. M., Juliá-Palacios, N., Darling, A., Ortigoza-Escobar, J. D., Fons, C., García-Cazorla, A., Perera-Lluna, A., & Artuch, R. (2024). Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae139

Vancouver

Rodriguez-Gonzalez H, Ormazabal A, Casado M, Arias AY, Oliva C, Barranco-Altirriba M, et al. Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae139

BibTeX
@article{RodriguezGonzalez2024,
  author = {Rodriguez-Gonzalez, Helena and Ormazabal, Aida and Casado, Mercedes and Arias, Angela Y and Oliva, Clara and Barranco-Altirriba, Maria and Casadevall, Ricard and García-Cuyas, Francesc and Nascimento, Andrés and Ortez, Carlos and Natera-de Benito, Daniel and Armangué, Thais and O'Callaghan, Maria M and Juliá-Palacios, Natalia and Darling, Alejandra and Ortigoza-Escobar, Juan Darío and Fons, Carmen and García-Cazorla, Angels and Perera-Lluna, Alexandre and Artuch, Rafael},
  title = {Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication},
  journal = {Clinical Chemistry},
  year = {2024},
  doi = {10.1093/clinchem/hvae139}
}
Kostenlos starten →